Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jan 14;288(6411):106–111. doi: 10.1136/bmj.288.6411.106

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

D McAreavey, L E Ramsey, L Latham, A D McLaren, A R Lorimer, J L Reid, J I Robertson, M P Robertson, R J Weir
PMCID: PMC1443950  PMID: 6419809

Abstract

Hydralazine, labetalol, methyldopa, minoxidil, prazosin, and placebo were compared when added by random allocation to atenolol 100 mg and bendrofluazide 5 mg daily in a series of 238 hypertensive patients inadequately controlled by the beta blocker-diuretic combination. Atenolol was withdrawn in those allocated to labetalol, and minoxidil was given only to men. The order of acceptability was: placebo, hydralazine, prazosin, methyldopa, minoxidil, labetalol. Minoxidil was more effective than the other active drugs, which had similar potency to one another. All the active agents were more effective than placebo. Hydralazine was the most generally suitable third drug, with prazosin a close second. Minoxidil was especially effective in patients with less severe hypertension but the same regimen caused fluid retention in those with more severe disease. Labetalol should probably be introduced at a low dose (150 mg daily) even when replacing full doses of a previously administered beta blocker.

Full text

PDF
111

Images in this article

111p111-a
on p.111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bing R. F., Russell G. I., Thurston H., Swales J. D. Hydrallazine in hypertension: is there a safe dose? Br Med J. 1980 Aug 2;281(6236):353–354. doi: 10.1136/bmj.281.6236.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bulpitt C. J., Dollery C. T., Carne S. A symptom questionnaire for hypertensive patients. J Chronic Dis. 1974 Aug;27(6):309–323. doi: 10.1016/0021-9681(74)90094-0. [DOI] [PubMed] [Google Scholar]
  3. Bulpitt C. J., Dollery C. T. Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J. 1973 Sep 1;3(5878):485–490. doi: 10.1136/bmj.3.5878.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Devine B. L., Fife R., Trust P. M. Minoxidil for severe hypertension after failure of other hypotensive drugs. Br Med J. 1977 Sep 10;2(6088):667–669. doi: 10.1136/bmj.2.6088.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hua A. S., Macdonald I. M., Myers J. B., Kincaid-Smith P. Studies with prazosin--a new effective hypotensive agent. I. Open clinical study of prazosin in combination with other antihypertensive agents. Med J Aust. 1976 Apr 17;1(16):559–561. [PubMed] [Google Scholar]
  6. Johnson B. F., Black H. R., Beckner R., Weiner B., Angeletti F. A comparison of minoxidil and hydralazine in non-azotemic hypertensives. J Hypertens. 1983 Jun;1(1):103–107. doi: 10.1097/00004872-198306000-00017. [DOI] [PubMed] [Google Scholar]
  7. Mackay A., Isles C., Henderson I., Fife R., Kennedy A. C. Minoxidil in the management of intractable hypertension. Q J Med. 1981 Spring;50(198):175–190. [PubMed] [Google Scholar]
  8. Meredith P. A., McSharry D., Elliott H. L., Reid J. L. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection. J Pharmacol Methods. 1981 Dec;6(4):309–314. doi: 10.1016/0160-5402(81)90070-x. [DOI] [PubMed] [Google Scholar]
  9. Moyer T. P., Jiang N. S., Tyce G. M., Sheps S. G. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem. 1979 Feb;25(2):256–263. [PubMed] [Google Scholar]
  10. Petrie J. C., Galloway D. B., Jeffers T. A., Millar H. R., Smith M. C., Wood R. A., Lewis J. A., Simpson W. T. Methyldopa and propranolol or practolol in moderate hypertension. Br Med J. 1976 Jul 17;2(6028):137–139. doi: 10.1136/bmj.2.6028.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Prichard B. N., Boakes A. J. Labetalol in long-term treatment of hypertension. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):743–750. [PubMed] [Google Scholar]
  12. Ramsay L. E. Diuretic and beta-blocker in hypertension--then what? J R Coll Physicians Lond. 1980 Oct;14(4):249–253. [PMC free article] [PubMed] [Google Scholar]
  13. Reece P. A., Cozamanis I., Zacest R. Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man. J Chromatogr. 1980 Mar 14;181(3-4):427–440. doi: 10.1016/s0378-4347(00)81145-7. [DOI] [PubMed] [Google Scholar]
  14. Stokes G. S., Weber M. A. Prazosin: preliminary report and comparative studies with other antihypertensive agents. Br Med J. 1974 May 11;2(5914):298–300. doi: 10.1136/bmj.2.5914.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Swales J. D., Bing R. F., Heagerty A., Pohl J. E., Russell G. I., Thurston H. Treatment of refractory hypertension. Lancet. 1982 Apr 17;1(8277):894–896. doi: 10.1016/s0140-6736(82)92162-6. [DOI] [PubMed] [Google Scholar]
  16. Tisdall P. A., Moyer T. P., Anhalt J. P. Liquid-chromatographic detection of thiazide diuretics in urine. Clin Chem. 1980 May;26(6):702–706. [PubMed] [Google Scholar]
  17. Webster J., Jeffers T. A., Galloway D. B., Petrie J. C., Barker N. P. Atenolol, methyldopa, and chlorthalidone in moderate hypertension. Br Med J. 1977 Jan 8;1(6053):76–78. doi: 10.1136/bmj.1.6053.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wilcox R. G., Mitchell J. R. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension. Br Med J. 1977 Aug 27;2(6086):547–550. doi: 10.1136/bmj.2.6086.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wright B. M., Dore C. F. A random-zero sphygmomanometer. Lancet. 1970 Feb 14;1(7642):337–338. doi: 10.1016/s0140-6736(70)90709-9. [DOI] [PubMed] [Google Scholar]
  20. Yee Y. G., Rubin P. C., Meffin P. Prazosin determination by high-pressure liquid chromatography using fluorescence detection. J Chromatogr. 1979 Apr 21;172:313–318. doi: 10.1016/s0021-9673(00)90967-1. [DOI] [PubMed] [Google Scholar]
  21. Yee Y. G., Rubin P., Blaschke T. F. Atenolol determination by high-performance liquid chromatography and fluorescence detection. J Chromatogr. 1979 Apr 1;171:357–362. doi: 10.1016/s0021-9673(01)95315-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES